INBS Intelligent Bio Solutions Inc. logo

INBS Intelligent Bio Solutions Inc.

Healthcare
$2.57-2.28%ClosedMarket Cap: $1.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.46

P/S

0.42

EV/EBITDA

0.32

DCF Value

$0.37

FCF Yield

-689.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

32.1%

Operating Margin

-300.3%

Net Margin

-296.8%

ROE

-174.2%

ROA

-78.1%

ROIC

-110.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$1.1M$-2.9M$
Q2 null$896.8K$-2.7M$
Q1 null$1.1M$-3.0M$
Q4 null$843.9K$-3.1M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Simeonidis Harryofficer: Chief Executive Officer
SellFri Mar 20
Simeonidis Harryofficer: Chief Executive Officer
SellFri Mar 20
Sakiris Spiro Kevinofficer: Chief Financial Officer
SellFri Mar 20
Sakiris Spiro Kevinofficer: Chief Financial Officer
SellFri Mar 20
Isenberg Jasondirector
SellFri Mar 20

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

4.24

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Peers